CERRAPINI LIMITED

Company Registration Number:
07999174 (England and Wales)

Unaudited statutory accounts for the year ended 31 March 2023

Period of accounts

Start date: 01 April 2022

End date: 31 March 2023

CERRAPINI LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2023

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

CERRAPINI LIMITED

Company Information

for the Period Ended 31 March 2023




Director: Heather Blake
Registered office: 19
Spencer Square
Ramsgate
Kent
England
CT11 9LA
Company Registration Number: 07999174 (England and Wales)

CERRAPINI LIMITED

Balance sheet

As at 31 March 2023


Notes

2023
£

2022
£
Fixed assets
Tangible assets: 4 0 576
Total fixed assets: 0 576
Current assets
Stocks: 5,969 14,273
Cash at bank and in hand: 11,015 115
Total current assets: 16,984 14,388
Creditors: amounts falling due within one year: 5 ( 14,690 ) ( 12,934 )
Net current assets (liabilities): 2,294 1,454
Total assets less current liabilities: 2,294 2,030
Total net assets (liabilities): 2,294 2,030

The notes form part of these financial statements

CERRAPINI LIMITED

Balance sheet continued

As at 31 March 2023


Notes

2023
£

2022
£
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 2,194 1,930
Shareholders funds: 2,294 2,030

For the year ending 31 March 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 22 October 2023
And Signed On Behalf Of The Board By:

Name: Heather Blake
Status: Director

The notes form part of these financial statements

CERRAPINI LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

CERRAPINI LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

  • 2. Employees


    2023

    2022
    Average number of employees during the period 0 0

CERRAPINI LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

  • 3. Off balance sheet disclosure

    No

CERRAPINI LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

4. Tangible assets

Office equipment Total
Cost £ £
At 01 April 2022 5,942 5,942
Additions - -
Disposals - -
Revaluations - -
Transfers - -
At 31 March 2023 5,942 5,942
Depreciation
At 01 April 2022 5,366 5,366
Charge for year 576 576
On disposals - -
Other adjustments - -
At 31 March 2023 5,942 5,942
Net book value
At 31 March 2023 0 0
At 31 March 2022 576 576

CERRAPINI LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

5.Creditors: amounts falling due within one year note


2023
£

2022
£
Accruals and deferred income 950 500
Other creditors 13,740 12,434
Total 14,690 12,934